Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multi-Center, Randomized, Open Label Trial to Determine if a Common Atrial Fibrillation Risk Locus Modulates Differential Response to Antiarrhythmic Drugs

NCT02347111 is registered in ClinicalTrials.gov with University of Illinois at Chicago as lead sponsor.

NCT NCT02347111
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02347111 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multi-Center, Randomized, Open Label Trial to Determine if a Common Atrial Fibrillation Risk Locus Modulates Differential Response to Antiarrhythmic Drugs
Lead sponsor
University of Illinois at Chicago
Phase
Phase 4
Overall status
Recruiting
Start date
December 31, 2020
Completion date
June 30, 2026
Enrollment
162 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation